XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
STATEMENTS OF CONSOLIDATED INCOME (LOSS) (UNAUDITED) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 748.9 $ 750.6 $ 2,651.9 $ 1,815.6
Costs and expenses:        
Cost of products sold, excluding depreciation and amortization and other items 694.9 677.8 2,459.2 1,613.6
Depreciation and amortization 25.8 24.9 80.4 64.2
Selling, general, administrative, research and development 25.2 28.1 82.9 90.8
Restructuring costs (benefit)       (0.8)
Other operating charges, net     3.2  
Total costs and expenses 745.9 730.8 2,625.7 1,767.8
Operating income 3.0 19.8 26.2 47.8
Other expense:        
Interest expense (12.1) (12.5) (36.5) (37.2)
Other income (expense), net - Note 8 12.7 (1.2) 7.4 (38.2)
Income (loss) before income taxes 3.6 6.1 (2.9) (27.6)
Income tax (provision) benefit (1.1) (8.4) (0.3) 7.4
Net income (loss) $ 2.5 $ (2.3) $ (3.2) $ (20.2)
Net income (loss) per common share:        
Basic $ 0.16 $ (0.14) $ (0.20) $ (1.28)
Diluted $ 0.16 $ (0.14) $ (0.20) $ (1.28)
Weighted-average number of common shares outstanding (in thousands):        
Basic 15,926 15,852 15,897 15,831
Diluted 16,029 15,852 15,897 15,831